For people throughout Newark and the surrounding Delaware area living with chronic knee or low back pain, the conversation about treatment options increasingly includes a genuine emphasis on non-opioid approaches, both because of the well-documented risks associated with long-term opioid use and because many patients simply want a treatment path that addresses the underlying pain signal rather than masking discomfort with medication that carries its own significant tradeoffs.
Peripheral nerve stimulation, often abbreviated as PNS, has become one of the more established non-opioid options for certain chronic pain conditions, and it works on a genuinely different principle than either medication or many surgical approaches.
Understanding what peripheral nerve stimulation actually is, how it differs from other stimulation-based therapies like spinal cord stimulation, who tends to be a reasonable candidate, and what the treatment process realistically looks like helps patients and their physicians have a more informed, productive conversation about whether it is worth pursuing for a specific case of knee or low back pain.
Peripheral nerve stimulation targets specific peripheral nerves, the nerves outside the brain and spinal cord that carry pain signals from a particular area of the body, rather than targeting the spinal cord itself the way spinal cord stimulation does.
A thin electrode lead is placed near the specific peripheral nerve identified as the source of a patient's pain, and that lead delivers mild electrical pulses designed to interfere with how pain signals travel along that nerve toward the brain, similar in underlying concept to spinal cord stimulation but applied at a more localized, targeted level rather than at the broader level of the spinal cord.
This targeted approach makes PNS particularly well suited to pain that is clearly tied to a specific, identifiable nerve or a well-defined anatomical area, such as certain knee pain conditions where a specific peripheral nerve, like the genicular nerves around the knee, is understood to be driving the pain, or certain low back pain presentations where a specific nerve distribution is the primary source of discomfort.
This differs meaningfully from spinal cord stimulation, which tends to be used for more diffuse or widespread pain patterns, such as pain affecting a larger region of the back and legs following failed back surgery.
Modern peripheral nerve stimulation systems are generally less invasive than spinal cord stimulator implantation, and many current PNS systems are designed to be minimally invasive from the outset, with a smaller lead placed through a needle procedure rather than a more involved surgical implantation, and some systems designed as fully removable, temporary therapies rather than permanent implants at all.
Patients exploring stimulation-based pain treatment options often want to understand how peripheral nerve stimulation and spinal cord stimulation actually differ, since both work on a broadly similar underlying principle of interrupting pain signal transmission through targeted electrical stimulation.
The key distinction is one of scope and target.
Spinal cord stimulation targets the spinal cord itself and tends to be appropriate for more widespread, diffuse pain patterns, often affecting a larger region of the body, such as pain radiating through the low back and into one or both legs.
Peripheral nerve stimulation targets a specific, identified peripheral nerve and tends to be more appropriate for pain that is clearly localized to the distribution of that particular nerve, such as pain concentrated around the knee joint or a specific, well-defined area of the low back.
The procedures involved also tend to differ in invasiveness.
Spinal cord stimulation typically involves a trial period followed by permanent implantation of a pulse generator connected to leads positioned in the epidural space.
Peripheral nerve stimulation, particularly with some of the newer systems available, can be a considerably less invasive process, in some cases involving a temporary lead placed for a defined treatment period, such as sixty days, after which the lead is removed entirely, with pain relief in appropriately selected patients sometimes persisting well beyond the active treatment period itself, since the stimulation is thought to produce longer-lasting changes in how the nerve processes pain signals rather than requiring permanent, ongoing stimulation to maintain benefit.
Neither treatment is inherently better than the other in a general sense.
The right choice depends entirely on the specific pain condition, its location, and a thorough individual evaluation, which is exactly why this decision should be made in consultation with a pain management specialist who can assess a specific patient's presentation against both options.
Peripheral nerve stimulation is most often considered for patients with chronic pain clearly tied to a specific peripheral nerve, following a diagnostic workup that has identified which nerve or nerves are likely driving the pain.
For knee pain specifically, this often applies to patients with chronic knee pain, including in some cases patients who are not ideal candidates for knee replacement surgery or who continue to experience pain following a knee replacement, where the genicular nerves supplying sensation to the knee joint have been identified as a meaningful contributor to ongoing pain.
For low back pain, candidacy typically depends on the pain being reasonably well localized to a specific nerve distribution rather than more diffuse, widespread discomfort, which is part of why a thorough diagnostic evaluation, sometimes including diagnostic nerve blocks to confirm that numbing a specific nerve meaningfully reduces the pain, is a standard part of determining whether PNS is likely to be effective for a given patient before moving forward with the actual stimulation therapy.
As with most interventional pain treatments, PNS is generally considered after more conservative treatments, including physical therapy, medication management, and often diagnostic and therapeutic injections, have been tried without providing adequate, lasting relief.
It is not typically a first-line treatment, and a thorough medical history and diagnostic workup remain an essential part of determining genuine candidacy rather than assuming any patient with knee or back pain is automatically a good fit.
For patients who are identified as reasonable candidates, the process typically begins with a diagnostic evaluation to confirm which specific nerve or nerves are involved, often including a diagnostic nerve block, a temporary numbing injection targeting the suspected nerve, to confirm that addressing that specific nerve meaningfully reduces the patient's pain before proceeding to stimulation therapy.
This diagnostic step is valuable precisely because it helps avoid moving forward with a stimulation therapy that is unlikely to be effective for a given patient's actual pain source.
Once a specific nerve target is confirmed, a thin lead is placed near that nerve through a minimally invasive, needle-based procedure, typically performed under imaging guidance to ensure accurate lead placement.
Depending on the specific system used, this lead may be connected to an external stimulator device that the patient wears for a defined treatment period, often around sixty days for certain temporary PNS systems, during which the patient continues normal daily activities while the device delivers stimulation according to a program set by their physician.
At the end of this defined treatment period, for temporary PNS systems, the lead is removed in a simple outpatient procedure, and patients are then monitored for how well pain relief persists beyond the active treatment window.
For appropriately selected patients, meaningful pain relief has been reported to continue well past the period of active stimulation in a meaningful number of cases, which is a genuinely distinct advantage of this therapy compared to treatments that only work while actively being administered.
As with any interventional pain treatment, it is important to approach peripheral nerve stimulation with realistic expectations rather than assuming it will completely eliminate pain for every patient.
The goal for most patients is a meaningful reduction in pain intensity and improved function, which for many appropriately selected patients translates into being able to participate more fully in physical therapy, daily activities, and in some cases delaying or avoiding a surgical procedure like knee replacement, rather than a guarantee of complete pain elimination.
Individual results vary considerably based on the specific pain condition, how clearly the pain is tied to the targeted nerve, and a range of individual patient factors, which is exactly why the diagnostic workup, including nerve blocks to confirm candidacy, matters so much in setting realistic expectations before treatment begins rather than after.
The emphasis on peripheral nerve stimulation as a non-opioid treatment option reflects something more substantial than simply preferring one type of treatment over another.
Long-term opioid use for chronic pain carries well-documented risks, including tolerance, meaning increasingly higher doses are needed over time to achieve the same effect, physical dependence, and the broader risks associated with opioid medications that have become a significant public health concern nationally.
Beyond these risks, opioid medications treat pain by dampening the perception of pain broadly throughout the nervous system, rather than addressing a specific pain source, which means they often come with side effects like sedation, constipation, and cognitive fog that can meaningfully affect a person's quality of life and ability to function, even when the medication is providing some degree of pain relief.
Peripheral nerve stimulation, by contrast, works by targeting the specific pain pathway involved rather than broadly dampening pain perception throughout the body, which means patients undergoing this treatment generally do not experience the same systemic side effects associated with opioid medication.
For patients who have been managing chronic knee or back pain with opioids for an extended period, a treatment option that offers a path toward reducing or eliminating that reliance, while still meaningfully addressing the underlying pain, represents a genuinely different and often welcome direction in their overall treatment plan.
This does not mean every patient using opioid medication for pain is an automatic candidate for PNS, since candidacy still depends on the specific pain condition and whether it is genuinely tied to an identifiable peripheral nerve.
But for appropriately selected patients, the conversation about PNS often includes real discussion about the goal of reducing opioid dependence as part of the broader treatment plan, which is a meaningful consideration for many patients and their physicians alike.
No. PNS targets a specific peripheral nerve outside the spinal cord, while spinal cord stimulation targets the spinal cord itself. PNS tends to suit more localized pain, while spinal cord stimulation tends to suit more widespread pain patterns.
Not necessarily. Some PNS systems are designed as temporary therapies, with a lead placed for a defined treatment period, often around sixty days, and then removed, while other systems are designed for longer-term or permanent use depending on the specific patient and condition.
A diagnostic nerve block, a temporary numbing injection targeting a suspected nerve, is commonly used to confirm that addressing that specific nerve meaningfully reduces pain before moving forward with stimulation therapy.
For some appropriately selected patients with chronic knee pain tied to the genicular nerves, PNS has been used as a treatment that may reduce pain and improve function, potentially delaying the need for surgery, though this depends entirely on individual evaluation and is a decision made together with your physician.
For certain temporary PNS systems, meaningful pain relief has been reported to persist well beyond the active treatment period in a meaningful number of appropriately selected patients, though individual results vary and this should be discussed as part of a realistic expectations conversation with your physician.
It may be worth discussing with a pain management specialist, since PNS is generally considered after more conservative treatments have not provided adequate relief, particularly when pain appears to be clearly tied to a specific, identifiable peripheral nerve.
This article is intended for general educational purposes and is not a substitute for personalized medical advice. Whether peripheral nerve stimulation is appropriate depends on an individual evaluation with a qualified pain management physician.
Chronic knee or low back pain that has not responded adequately to conservative treatment deserves a thorough evaluation to determine whether a targeted, non-opioid option like peripheral nerve stimulation could help.
The team at Delaware Spine & Interventional Pain, led by Dr. John Rowlands and Dr. Amir Kader, takes the time to identify the actual source of a patient's pain and walk through whether PNS or another treatment approach is the right fit.
Call us at (302) 366-2200 or visit delawarespineandpain.com to schedule a consultation at our Newark location, 774 Christiana Rd, Suite 201, Newark, DE 19713.
Minimally Invasive Specialty Care. Providing motion preserving spine solutions and cutting edge minimally invasive techniques.